(G) Genpact - Ratings and Ratios

Exchange: NYSE • Country: Bermuda • Currency: USD • Type: Common Stock • ISIN: BMG3922B1072

Outsourcing, Services

Data Processing & Outsourced Services
Market Cap in USD: 8,407m

IPO / Inception: 2007-08-02
12m vs SPY: -11.7%

EPS (Earnings per Share)

EPS CAGR: -44.52%
EPS Trend: -7.7%

Last SUE: -4.00
Qual. Beats: 0

Revenue

Rev. CAGR: 5.08%
Rev. Trend: 95.3%

Last SUE: 1.17
Qual. Beats: 2

Dividends

Dividend Yield	1.50%
Yield on Cost 5y	1.77%
Yield CAGR 5y	12.01%
Payout Consistency	58.5%
Payout Ratio	18.9%

Risk via 5d forecast
Volatility	27.8%
Value at Risk 5%th	39.0%
Relative Tail Risk	-14.59%

Reward TTM
Sharpe Ratio	0.23
Alpha	-5.31
CAGR/Max DD	0.04

Character TTM
Hurst Exponent	0.457
Beta	0.605
Beta Downside	0.608

Drawdowns 3y
Max DD	35.61%
Mean DD	19.16%
Median DD	20.86%

Description: G Genpact January 06, 2026

Genpact Limited (NYSE:G) is a Bermuda-incorporated provider of business process outsourcing (BPO) and information-technology services, operating across India, the rest of Asia, North and Latin America, and Europe.

The firm is organized into three operating segments: Financial Services, Consumer & Healthcare, and High-Tech & Manufacturing. Each segment delivers end-to-end solutions ranging from customer onboarding and loan processing to supply-chain planning, digital commerce, and engineering support.

Key performance indicators from the most recent fiscal year show revenue of roughly **$4.0 billion**, a **5 % year-over-year growth** driven largely by digital-transformation contracts, and an **operating margin near 13 %** after continued investment in AI-enabled automation.

Sector-level drivers that underpin Genpage’s outlook include accelerating demand for **cloud-based BPO services**, heightened regulatory compliance spending in financial services, and the **near-shoring trend** that pushes U.S. firms to outsource to lower-cost but high-skill locations such as India and Eastern Europe.

Analysts note that Genpact’s **backlog of signed contracts grew 8 % YoY**, indicating a robust pipeline that could sustain earnings growth even if macro-economic conditions soften.

For a deeper, data-rich assessment of Genpact’s valuation dynamics, you might explore the company’s profile on ValueRay to see how its risk-adjusted metrics compare to peers.

Piotroski VR‑10 (Strict, 0-10) 9.5

Net Income (551.3m TTM) > 0 and > 6% of Revenue (6% = 300.6m TTM)

FCFTA 0.12 (>2.0%) and ΔFCFTA 2.23pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)

NWC/Revenue 14.99% (prev 23.71%; Δ -8.72pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)

CFO/TA 0.14 (>3.0%) and CFO 729.4m > Net Income 551.3m (YES >=105%, WARN >=100%)

Net Debt (688.3m) to EBITDA (887.4m) ratio: 0.78 <= 3.0 (WARN <= 3.5)

Current Ratio 1.51 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)

Outstanding Shares last Quarter (176.1m) change vs 12m ago -2.63% (target <= -2.0% for YES)

Gross Margin 35.82% (prev 35.41%; Δ 0.41pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)

Asset Turnover 93.72% (prev 87.59%; Δ 6.13pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)

Interest Coverage Ratio 11.47 (EBITDA TTM 887.4m / Interest Expense TTM 69.1m) >= 6 (WARN >= 3)

Altman Z'' 2.96

(A) 0.14 = (Total Current Assets 2.21b - Total Current Liabilities 1.46b) / Total Assets 5.36b

(B) 0.26 = Retained Earnings (Balance) 1.37b / Total Assets 5.36b

(D) 0.20 = Book Value of Equity 552.8m / Total Liabilities 2.82b

Total Rating: 2.96 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 85.93

1. Piotroski 9.50pt

2. FCF Yield 7.10%

3. FCF Margin 12.89%

4. Debt/Equity 0.56

5. Debt/Ebitda 0.78

6. ROIC - WACC (= 9.33)%

7. RoE 22.11%

8. Rev. Trend 95.31%

9. EPS Trend -7.70%

What is the price of G shares?

As of January 14, 2026, the stock is trading at USD 46.52 with a total of 1,128,966 shares traded.
Over the past week, the price has changed by -1.75%, over one month by -1.75%, over three months by +18.15% and over the past year by +6.57%.

Is G a buy, sell or hold?

Genpact has received a consensus analysts rating of 3.91. Therefore, it is recommended to buy G.

Strong Buy: 4
Buy: 2
Hold: 5
Sell: 0
Strong Sell: 0

What are the forecasts/targets for the G price?

Issuer	Target	Up/Down from current
Wallstreet Target Price	50.9	9.4%
Analysts Target Price	50.9	9.4%
ValueRay Target Price	47	1%

G Fundamental Data Overview January 12, 2026

P/E Trailing = 15.5613
P/E Forward = 18.315
P/S = 1.6782
P/B = 3.2687
P/EG = 1.7
Beta = 0.755
Revenue TTM = 5.01b USD
EBIT TTM = 793.0m USD
EBITDA TTM = 887.4m USD
Long Term Debt = 827.0m USD (from longTermDebt, last quarter)
Short Term Debt = 437.5m USD (from shortTermDebt, last quarter)
Debt = 1.43b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 688.3m USD (from netDebt column, last quarter)
Enterprise Value = 9.10b USD (8.41b + Debt 1.43b - CCE 740.8m)
Interest Coverage Ratio = 11.47 (Ebit TTM 793.0m / Interest Expense TTM 69.1m)
EV/FCF = 14.09x (Enterprise Value 9.10b / FCF TTM 645.5m)
FCF Yield = 7.10% (FCF TTM 645.5m / Enterprise Value 9.10b)
FCF Margin = 12.89% (FCF TTM 645.5m / Revenue TTM 5.01b)
Net Margin = 11.01% (Net Income TTM 551.3m / Revenue TTM 5.01b)
Gross Margin = 35.82% ((Revenue TTM 5.01b - Cost of Revenue TTM 3.21b) / Revenue TTM)
Gross Margin QoQ = 36.37% (prev 35.88%)
Tobins Q-Ratio = 1.70 (Enterprise Value 9.10b / Total Assets 5.36b)
Interest Expense / Debt = 0.89% (Interest Expense 12.8m / Debt 1.43b)
Taxrate = 22.98% (43.5m / 189.4m)
NOPAT = 610.7m (EBIT 793.0m * (1 - 22.98%))
Current Ratio = 1.51 (Total Current Assets 2.21b / Total Current Liabilities 1.46b)
Debt / Equity = 0.56 (Debt 1.43b / totalStockholderEquity, last quarter 2.54b)
Debt / EBITDA = 0.78 (Net Debt 688.3m / EBITDA 887.4m)
Debt / FCF = 1.07 (Net Debt 688.3m / FCF TTM 645.5m)
Total Stockholder Equity = 2.49b (last 4 quarters mean from totalStockholderEquity)
RoA = 10.31% (Net Income 551.3m / Total Assets 5.36b)
RoE = 22.11% (Net Income TTM 551.3m / Total Stockholder Equity 2.49b)
RoCE = 23.88% (EBIT 793.0m / Capital Employed (Equity 2.49b + L.T.Debt 827.0m))
RoIC = 16.39% (NOPAT 610.7m / Invested Capital 3.73b)
WACC = 7.06% (E(8.41b)/V(9.84b) * Re(8.14%) + D(1.43b)/V(9.84b) * Rd(0.89%) * (1-Tc(0.23)))
Discount Rate = 8.14% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -2.00%
[DCF Debug] Terminal Value 83.08% ; FCFF base≈596.1m ; Y1≈670.4m ; Y5≈897.6m
Fair Price DCF = 106.3 (EV 19.02b - Net Debt 688.3m = Equity 18.33b / Shares 172.4m; r=7.06% [WACC]; 5y FCF grow 14.47% → 2.90% )
EPS Correlation: -7.70 | EPS CAGR: -44.52% | SUE: -4.0 | # QB: 0
Revenue Correlation: 95.31 | Revenue CAGR: 5.08% | SUE: 1.17 | # QB: 2
EPS next Quarter (2026-03-31): EPS=0.91 | Chg30d=+0.005 | Revisions Net=+1 | Analysts=11
EPS next Year (2026-12-31): EPS=3.95 | Chg30d=+0.014 | Revisions Net=+7 | Growth EPS=+9.2% | Growth Revenue=+7.0%

Additional Sources for G Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle